Article
Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy.
Therapeutic drug monitoring - 1 Dec 2004
Laine Kari, Kytölä Jaakko, Bertilsson Leif
Abstract excerpt
Paroxetine, like other SSRIs, is reported not to increase the number of malformations in infants exposed to these drugs in utero. However, late pregnancy exposure to SSRIs sometimes leads to perinatal complications resembling the symptoms seen in serotonergic overstimulation. We report here a case of third trimester paroxetine exposure with adverse birth outcome in a newborn. The clinical symptoms in the infant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.